Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections
- 14 December 2017
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 37 (4) , 679-689
Abstract
The prevalence of hypervirulent Klebsiella pneumoniae (hvKP) is high in China, but clinical characteristics and outcomes of hvKP induced bloodstream infections (BSIs) are not clear. The purpose of the present study was to determine the risk factors and clinical outcomes of hvKP-BSIs in populations admitted in a teaching hospital of Nanjing, China. The genetic characteristics and antibiotic resistance patterns of the hvKP strains were further analyzed. A retrospective study was conducted in 143 patients with K. pneumoniae BSIs at Jinling Hospital in China from September 2015 to December 2016. A positive polymerase chain reaction (PCR) amplification of the plasmid-borne rmpA (p-rmpA) and aerobactin (iucA) was identified as hvKP. Overall, 24.5% (35/143) of K. pneumoniae isolates were hvKP. Multivariate analysis implicated diabetes mellitus (OR = 3.356) and community-acquired BSIs (OR = 4.898) as independent risk factors for hvKP-BSIs. The 30-day mortality rate of the hvKP-BSIs group was 37.1% (13/35) compared with 40.7% (44/108) in the cKP-BSIs control group (P = 0.706). The KPC-producing isolates (OR = 2.851), underlying disease with gastrointestinal fistula (OR = 3.054), APACHE II score ≥ 15 (OR = 6.694) and Pitt bacteremia score ≥ 2 (OR = 6.232) at infection onset were independent predictors for 30-day mortality of K. pneumoniae bacteremia patients. A high percentage (57.1%, 20/35) of KPC-producing isolates was observed among hvKP strains and ST11 was dominant in hvKP strains (17/35, 48.6%). KPC-producing hvKP is emerging, indicating the importance of epidemiologic surveillance and clinical awareness of this pathogen.Keywords
Funding Information
- Key Project of Jiangsu Social Development (BE2016752)
- Innovation Project of Military Medicine (16CXZ006)
This publication has 40 references indexed in Scilit:
- Prevalence and Antimicrobial Susceptibility of Hypervirulent Klebsiella pneumoniae Isolates in ChinaClinical Infectious Diseases, 2014
- Increasing Occurrence of Antimicrobial-Resistant Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae Isolates in ChinaClinical Infectious Diseases, 2013
- Hypervirulent (hypermucoviscous)Klebsiella pneumoniaeVirulence, 2013
- Klebsiella pneumoniae liver abscess: a new invasive syndromeThe Lancet Infectious Diseases, 2012
- The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisitedMicrobiology, 2011
- Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variantEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in ChinaJournal of Antimicrobial Chemotherapy, 2010
- Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypesDiagnostic Microbiology and Infectious Disease, 2008
- Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community‐acquired bacteraemiaJournal of Internal Medicine, 2006
- A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis?Gut, 2002